Increased school absence among children with juvenile idiopathic arthritis - a national matched comparison study - Articles - Dermatology · Immunology · Rheumatology

Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Arthritis Care Res (Hoboken)

Miller H, Neovius M, Sundberg E, Askling J, Bruze G

doi: 10.1002/acr.25522

Juvenile Idiopathic Arthritis

Intravenous Golimumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis: Long-term Extension of an Open-label, Phase 3 Study

J Rheumatol

Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, Chasnyk V, Griffin T, Navarrete Suarez C, Knupp-Oliveira S, Zeft A, Butbul Aviel Y, De Ranieri D, Gottlieb BS, Levy DM, Rabinovich CE, Artur Silva C, Spivakovsky Y, Uziel Y, Ringold S, Xu XL, Leu JH, Lam E, Wang Y, Lovell DJ, Martini A, Ruperto N, Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology INternational Trials Organisation (PRINTO)

doi: 10.3899/jrheum.2024-0298

Juvenile Idiopathic Arthritis

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

Ann Rheum Dis

Brunner HI, Akikusa JD, Al-Abadi E, Bohnsack JF, Boteanu AL, Chedeville G, Cuttica R, De La Pena W, Jung L, Kasapcopur O, Kobusinska K, Schulert GS, Neiva C, Rivas-Chacon R, Rizo Rodriguez JC, Vazquez-Del Mercado M, Wagner-Weiner L, Weiss JE, Wouters C, Posner H, Wouters A, Chang C, White C, Kanik K, Liu S, Martini A, Lovell DJ, Ruperto N

doi: 10.1136/ard-2023-225094

Further Publications Rheumatology

Neighborhood Characteristics & Walking Behavior Among Adults with Arthritis: An NHIS Study

Arthritis Care Res (Hoboken)

Pocha C, Chrusciel T, Salas J, Eisen S, Callahan L, Ory MG, Scherrer JF, Gebauer S

doi: 10.1002/acr.25418

EULAR 2024

Juvenile Idiopathic Arthritis

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Juvenile Idiopathic Arthritis

Incidence of juvenile idiopathic arthritis in Finland, 2000-2020

Rheumatology (Oxford)

Uusitupa E, Rahikkala H, Sard S, Pokka T, Salo H, Kärki J, Sokka-Isler T, Backström M, Vähäsalo P

doi: 10.1093/rheumatology/keae322

Juvenile Idiopathic Arthritis

Exploring pain adaptation in youth with juvenile idiopathic arthritis: Identifying youth and parent resilience resources and mechanisms

Arthritis Care Res (Hoboken)

Brandelli YN, Mackinnon SP, Chambers CT, Parker JA, Huber AM, Stinson JN, Johnson SA, Wilson JP

doi: 10.1002/acr.25439

Juvenile Idiopathic Arthritis

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Arthritis Rheumatol

Tordoff M, Smith SL, Lawson-Tovey S, UK JIA Biologics Register, CAPS, CHARMS, CLUSTER, JIAGC, Dick AD, Beresford MW, Ramanan AV, Hyrich KL, Morris AP, Eyre S, Wedderburn LR, Bowes J, CLUSTER consortium

doi: 10.1002/art.42955

Rheumatoid Arthritis

Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study

Ann Rheum Dis

Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, Cheng Y, Lin AT, Solano Z, De Jesus J, Amundsen B, Florea A, Ku JH, Chmielewski-Yee E, Oraichi D, Seifert H, Yun H, Tseng HF

doi: 10.1016/j.ard.2025.01.045

Related content

Juvenile Idiopathic Arthritis, Earnings and Work Loss: A Nationwide Matched Cohort Study

Intravenous Golimumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis: Long-term Extension of an Open-label, Phase 3 Study

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

Neighborhood Characteristics & Walking Behavior Among Adults with Arthritis: An NHIS Study

Canakinumab is effective as a first-line steroid-free treatment for patients with systemic juvenile idiopathic arthritis

Incidence of juvenile idiopathic arthritis in Finland, 2000-2020

Exploring pain adaptation in youth with juvenile idiopathic arthritis: Identifying youth and parent resilience resources and mechanisms

Integration of genetic and clinical risk factors improves the risk classification of uveitis in patients with juvenile idiopathic arthritis

Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study